Essa Pharma
Our Science
  • . Phase 1/2 Trial of Oral EPI-7386 (masofaniten) in Combination with Enzalutamide (Enz) Compared with Enz Alone in Subjects with Metastatic Castration-Resistant Prostate Cancer (mCRPC): Phase 1 results and Phase 2 design.

    Poster ASCO GU 2024